Antifibrotic therapy by sustained release of low molecular weight heparin from poly(lactic-co-glycolic acid) microparticles on bleomycin-induced pulmonary fibrosis in mice

Heparin and low molecular weight heparin (LMWH) have recently been considered useful treatment tools for inflammation. Heparin has antifibrotic activity, mediated by cellular secretion of hepatocyte growth factor (HGF). HGF has antifibrotic properties demonstrated in experimental models of lung, kid...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Takashi, Kotani, Takuya, Suzuki, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642430/
https://www.ncbi.nlm.nih.gov/pubmed/33149192
http://dx.doi.org/10.1038/s41598-020-76034-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642430/
https://www.ncbi.nlm.nih.gov/pubmed/33149192
http://dx.doi.org/10.1038/s41598-020-76034-0

Ejemplares similares